Advancing access to genome sequencing for rare genetic disorders: recent progress and call to action

Affiliations

• ¹ Molecular Diagnostics, New York Genome Center, New York, NY, USA. vjobanputra@nygenome.org.
• ² Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA. vjobanputra@nygenome.org.
• ³ Market Access, Illumina Inc., San Diego, CA, USA.
• ⁴ Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ⁵ Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
• ⁶ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
• ⁷ Clinical Genomics, Department of Pathology, Stanford Medicine, Palo Alto, CA, USA.
• ⁸ HudsonAlpha Clinical Services Lab, LLC, HudsonAlpha Institute for Biotechnology, Birmingham, AL, USA.
• ⁹ Medical Affairs, Illumina Inc., San Diego, CA, USA.
• ¹⁰ Division of Genome Diagnostics, Pediatric Laboratory Medicine Department, The Hospital for Sick Children, Toronto, ON, Canada.
• ¹¹ Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
• ¹² Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA, USA.
• ¹³ Stanford Center for Undiagnosed Diseases, Stanford University, Stanford, CA, USA.
• ¹⁴ Medical Genomics Research, Illumina Inc., San Diego, CA, USA.